Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Annaly Capital Management, Inc. (NLY) vs 22nd Century Group Inc (XXII) Price & Performance

Annaly Capital Management, Inc.Trade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Annaly Capital Management, Inc. vs 22nd Century Group Inc — how do they compare? Annaly Capital Management, Inc. trades at $18.31 (market cap $13.77B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Annaly Capital Management, Inc. is far larger — about 22150× 22nd Century Group Inc's market cap, and Annaly Capital Management, Inc. pays a 16.42% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Annaly Capital Management, Inc. for 91 Days and 22nd Century Group Inc for 32 Days on average.

NLYXXII
Market Cap
$13.77B$621.67K
Volume
21,283,87945,625
Sector
Real EstateConsumer Staples
52-Week High
$24.40$483.00
52-Week Low
$17.93$0.80
Typical Hold Time
91 Days32 Days
Enterprise Value
$135.80B-$3.69M
Dividend Yield
16.42%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Annaly Capital Management, Inc.

NLY trades at $18.30, up 2.06% today, with a bearish technical signal from moving averages but oversold RSI readings. The stock shows strong profitability with a 92.77% net income margin and a low P/E of 4.41. Recent earnings have consistently beaten estimates, and the company maintains a high dividend yield near 15%, supported by a $0.75 quarterly payout announced for Q3 2026.

The outlook is mixed: attractive valuation and high yield offer upside potential, but significant cash flow volatility and rising debt-to-asset ratio pose risks. Analyst consensus is bullish with a $22.00 price target, yet technical weakness and interest rate sensitivity warrant caution for near-term performance.

22nd Century Group Inc

22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.

While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NLY
70% Buy30% Sell
Avg holding period · 91 Days
XXII
100% Buy0% Sell
Avg holding period · 32 Days

Top news

Latest headlines on both assets

About Annaly Capital Management, Inc.

Annaly Capital Management Inc is an American mortgage real estate investment trust. The company segments its operations into Residential and Commercial real estate investments. While Annaly's Residential assets are primarily comprised of agency mortgage-backed securities and debentures, it is primarily invested in commercial mortgage loans and mortgage-backed securities in its Commercial unit through its subsidiary, Annaly Commercial Real Estate Group. Agency mortgage-backed securities and debentures make up the majority of the company's overall portfolio. Most of the company's counterparties are located in the U.S. Annaly generates nearly all of its revenue from the spread between interest earned on its assets and interest payments made on its borrowings.

Read more on NLY →

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII →